Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Search
The Faintest Ink: Documentation to Defend Quality Patient Care
Complete and timely documentation of the medical record not only enhances patient care, but it also serves to strengthen your credibility if you are called upon to defend that care.
Plastic Surgery Closed Claims Study Reveals Most Common Case Types
In this study of plastic surgery closed claims, The Doctors Company looks at the most common case types, most common patient injuries, primary drivers / frequent allegations, and strategies for mitigating risk for both cosmetic and reconstructive surgery.
Cognitive Assessments in Primary Care: Preparation and Tools May Mitigate Diagnosis Risks
As practices care for the increase in older patients and take advantage of the CMS billing rules, successfully integrating cognitive evaluations into a practice’s workflow without magnifying liability risks takes some preparation.
April 22, 2024, Part B News
Measles in Your Office? Follow CDC Rules, Take Caution in Telling Patients
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses the importance of patient communication and disclosure surrounding possible measles exposure.
February 20, 2023, KevinMD
From Toys to Tragedy: The Threat of Button Batteries to Children’s Health
This article by Patti L. Ellis, RN, CPHRM, Patient Safety Risk Manager II, The Doctors Company, discusses important lessons learned and risk prevention strategies for button battery ingestion in children.
April 13, 2022, Medical Economics
Why Patients Sue Their Doctor
Robert E. White, Jr., Chief Operating Officer of The Doctors Company and TDC Group, details why most lawsuits occur due to patient frustration with not getting answers to their questions regarding an unexpected outcome.
February 17, 2025, FDA Storm Proof: Plan for Every Possible Path
Disaster Preparedness for Your Dental Practice
Julie M. Brightwell, BSN, JD, RN, CPHRM, Director, Patient Safety, The Doctors Company, part of TDC Group, provides disaster preparedness recommendations for dental practices.
October 01, 2024, Cardiology Magazine
Misdiagnosis: Lessons Learned From a Cardiology Malpractice Case
This article, co-authored by Debra Davidson, MJ, CPHRM, CPPS, Senior Patient Safety Risk Manager for The Doctors Company, discusses how delayed diagnosis of myocardial infarction (MI) is a top malpractice allegation in cardiology.
For Members of The Doctors Company
Access tools to manage your account and stay up to date on your industry-leading member benefits.
